Edition:
United States

CanBas Co Ltd (4575.T)

4575.T on Tokyo Stock Exchange

790JPY
8:56pm EDT
Change (% chg)

¥5 (+0.64%)
Prev Close
¥785
Open
¥793
Day's High
¥797
Day's Low
¥781
Volume
1,600
Avg. Vol
32,208
52-wk High
¥855
52-wk Low
¥571

Latest Key Developments (Source: Significant Developments)

CanBas signs joint research agreement for pharma valley project
Tuesday, 26 Apr 2016 11:00pm EDT 

CanBas Co Ltd:Says it signed joint research agreement with a Japan-based public incorporated foundation regarding drug screening by using the compound library in pharma valley center, for research and development of anticancer drugs that targeting human cancer.  Full Article

CanBas receives patent for anticancer drug candidate compound CBS9106 from European Patent Office
Wednesday, 28 Oct 2015 02:00am EDT 

CanBas Co Ltd:Received patent for its anticancer drug candidate compound CBS9106 named COMPOUNDS WITH ANTI-CANCER ACTIVITY from European Patent Office.  Full Article

CanBas receive decision to grant patent in U.S
Sunday, 4 Oct 2015 07:50pm EDT 

CanBas Co Ltd:Receive decision to grant a patent from US Patent Office, for PEPTIDES AND PEPTIDOMIMETICS IN CONBINATION USES AND TREATMENTS FOR CANCER PATIENT SUBPOPULATIONS, which is a new application for anticancer drug candidate compound CBP501.  Full Article

CanBas amends consolidated full-year outlook for FY 2015
Tuesday, 16 Jun 2015 02:20am EDT 

CanBas Co Ltd:Says the company amended the consolidated full-year outlook for revenue to 60 million yen from 60 ~ 1060 million yen for FY ending June 2015.Sees a decrease of operating profit forecast to -281 million yen from -255 million yen ~ 744 million yen.Sees a decrease of ordinary profit forecast to - 265 million yen from -242 million yen ~ 757 million yen.Sees a decrease of net profit forecast to - 266 million yen from -242 million yen ~ 757 million yen.Sees a decrease of earnings per share to -62.35 yen from -56.17 yen ~ 174 yen.  Full Article

More From Around the Web